Ikuko Ota
Overview
Explore the profile of Ikuko Ota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kitahara Y, Hiraike O, Ishikawa H, Kugu K, Takai Y, Yoshino O, et al.
J Obstet Gynaecol Res
. 2024 Sep;
50(10):1785-1794.
PMID: 39234899
Aim: To present evidence- and consensus-based recommendations for the diagnosis abnormal uterine bleeding. Methods: A literature search for the diagnosis of abnormal uterine bleeding was systematically conducted in PubMed from...
2.
Kitahara Y, Hiraike O, Ishikawa H, Kugu K, Takai Y, Yoshino O, et al.
J Obstet Gynaecol Res
. 2024 Jun;
50(9):1675-1680.
PMID: 38925169
Aim: To clarify the diagnostic process of the causative disease of abnormal uterine bleeding (AUB) in Japan according to the International Federation of Gynecology and Obstetrics AUB diagnostic system. Methods:...
3.
Maekawa R, Ota Y, Ota I, Mihara Y, Takasaki H, Sato S, et al.
Reprod Med Biol
. 2023 Dec;
22(1):e12548.
PMID: 38107653
Purpose: To test the theory that invaginated ovarian surface epithelium and endometrial implants on the ovary form ovarian endometriomas. Methods: Adhesion sites of ovarian endometrioma on the peritoneum and consecutive...
4.
Suzuki C, Yamada A, Kawashima K, Sasamoto M, Fujiwara Y, Adachi S, et al.
World J Oncol
. 2023 Nov;
14(6):551-557.
PMID: 38022398
Background: With a prevalence of only 1% among all breast cancers in Japan, apocrine carcinoma (AC) is a rare type of breast cancer, and its clinicopathological characteristics remain unclear. The...
5.
Sasamoto M, Yamada A, Oshi M, Ota I, Yoshida K, Yakeishi M, et al.
Gland Surg
. 2023 Jul;
12(6):853-859.
PMID: 37441009
Background: Spontaneous regression (SR) of cancer is a rare condition in which the cancer partially or completely disappears without treatment. We report a case of breast cancer with tumor regression...
6.
Text mining in a literature review of abnormal uterine bleeding according to the FIGO classification
Ono M, Hiraike O, Kitahara Y, Maekawa R, Ota I, Yoshino O, et al.
J Obstet Gynaecol Res
. 2023 May;
49(7):1827-1837.
PMID: 37170675
Aim: Abnormal uterine bleeding, as proposed in 2007, is defined as unexpected uterine bleeding in women of reproductive age; the cause of the bleeding is categorized using the PALM-COEIN system....
7.
Ota I, Ota Y, Ota K, Eda H, Ohta H
JBMR Plus
. 2022 Nov;
6(11):e10690.
PMID: 36398113
Although changes in bone mineral density (BMD) are important indexes in osteoporosis treatment, no markers are available to predict them. Given the importance of assessing the therapeutic windows of antiresorptives,...
8.
Kitahara Y, Hiraike O, Ishikawa H, Kugu K, Takai Y, Yoshino O, et al.
J Obstet Gynaecol Res
. 2022 Oct;
49(1):321-330.
PMID: 36258286
Aim: To investigate the status of abnormal uterine bleeding (AUB) in Japan using the International Federation of Gynecology and Obstetrics (FIGO) classification (AUB system 1 and 2; PALM-COEIN) and to...
9.
Harada T, Ota I, Kitawaki J, Momoeda M, Maeda N, Akira S, et al.
Contraception
. 2022 Sep;
116:22-28.
PMID: 36057322
Objectives: We collected real-world data on the safety and clinical outcomes of the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding and dysmenorrhea. Study Design: This was a prospective, multicenter,...
10.
Momoeda M, Akira S, Harada T, Kitawaki J, Maeda N, Ota I, et al.
Adv Ther
. 2022 Jun;
39(8):3616-3634.
PMID: 35705788
Introduction: The present study collected 1-year follow-up patient-reported outcome data from Japanese women with dysmenorrhea and/or heavy menstrual bleeding (HMB) who underwent insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) 52 ...